![](https://endpts.com/wp-content/uploads/2023/09/Harbinger-health-lab.jpg)
A scientist in the lab at Harbinger Health (Credit: Harbinger Health)
Stephen Hahn’s liquid biopsy company Harbinger Health raises $140M Series B to launch first cancer tests by 2025
Harbinger Health, a startup with ambitious goals to develop liquid biopsies that spot signs of cancer early, has raised $140 million in Series B funding …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.